Gum disease and heart disease travel together. Causation has not been shown.

People with gum disease do have more cardiovascular disease than people without it, and after more than a decade of dedicated investigation nobody has shown that treating the gums prevents heart attacks or strokes. The American Heart Association's 2012 scientific statement concluded that observational studies support an association independent of known confounders but "do not, however, support a causative relationship", and that there is no evidence periodontal interventions prevent atherosclerotic vascular disease or modify its outcomes [s1]. The evidence published since has narrowed the association rather than strengthened the causal claim [s3] [s4].

Why the association exists is not mysterious

Both conditions are common and share several of the same drivers. The AHA statement lists cigarette smoking, age and diabetes mellitus among the risk factors common to periodontal disease and atherosclerotic vascular disease [s1]. Each of those independently raises the risk of both. A correlation between two conditions with three shared causes is the expected result, not a finding requiring a new mechanism.

The AHA also flagged something rarely mentioned in consumer coverage: patients and providers are increasingly presented with claims that treating periodontal disease offers cardiovascular protection, and those claims are often endorsed by professional and industrial stakeholders [s1]. A financial interest does not make a claim false. It does explain why this particular claim circulates far more widely than its evidence supports.

The scale of both diseases keeps the question live. A 2020 consensus report from a joint workshop of the European Federation of Periodontology and the World Heart Federation records that cardiovascular disease is responsible for 3.9 million deaths in Europe — 45% of all deaths — and that severe periodontitis affects 11.2% of the world's population, making it the sixth most common human disease [s2]. That workshop updated the epidemiological evidence, the proposed mechanistic links, and the impact of periodontal therapy on cardiovascular and surrogate outcomes, and issued recommendations for dentists, physicians and patients [s2].

How big the association actually is

A 2026 synthesis published in the International Journal of Dental Hygiene took a different approach from the usual meta-analysis: it screened 446 systematic reviews, included 19, and examined the 27 meta-analyses those reviews contained [s3].

Its central result concerns magnitude rather than significance. The majority — 78% — of the reported risk ratios and odds ratios linking periodontal disease to cardiovascular disease were estimated to show a negligible magnitude of association [s3]. For cardiovascular events, drawn from 23 meta-analyses, 46% of the values were considered to be of small magnitude [s3]. The authors also formally assessed the Bradford Hill criteria — the standard checklist for inferring causation from association — and reported that a definitive confirmation of causality was not attainable [s3]. Their overall grading was moderate certainty for a predominantly negligible to small association [s3].

The statistical significance of an association and the size of it are different things, and in a literature built from very large observational cohorts, the first can be achieved with almost nothing of the second. That is what this synthesis documents.

What genetics adds

Mendelian randomisation uses inherited genetic variants as natural experiments, on the logic that genotype is assigned at conception and cannot be confounded by smoking, income or diet. A 2026 study in BDJ Open applied bidirectional and multivariable Mendelian randomisation to periodontitis and five types of cardiovascular disease using genome-wide association summary data [s4].

The analysis confirmed that the association between cardiovascular disease and periodontitis is not driven by a direct causal relationship [s4]. The two conditions do share genetic architecture: colocalisation identified shared causal variants at loci 4p14 and 15q25.1, and seven pleiotropic genes were annotated, including CD151, POLR2L and HLA-DQA1, with pathway analysis pointing to an inflammation-metabolism regulatory axis [s4]. Tissue enrichment placed those signals in immune-related tissues and disease-relevant sites including the heart [s4].

Shared genetic architecture is a real finding and a different one from causation. The authors state the limit themselves: working from summary-level data, it remains unclear whether the association represents direct biological genetic determinants or indirect pathways mediated by shared environmental or behavioural risk factors [s4].

What would settle it, and why nobody has done it

The study design that would answer the question is a large randomised trial in which people with periodontitis are assigned to intensive periodontal treatment or usual care and followed for cardiovascular events over years. Short-term trials have shown that periodontal treatment reduces systemic inflammation and improves endothelial function — surrogate markers — but the AHA's assessment of what that establishes was blunt in 2012 and has not been overturned: there is no evidence that periodontal interventions prevent atherosclerotic vascular disease or modify its outcomes [s1].

Surrogate endpoints have a poor record of predicting hard outcomes across cardiology, and a reduction in an inflammatory marker is not a prevented heart attack.

The honest position

Gum disease is worth treating because it damages gums and teeth, causes pain and tooth loss, and affects one in nine people worldwide in its severe form [s2]. Whether treating it also protects the heart is an open question that has resisted answering for more than a decade, and the most recent evidence points toward a smaller association than the earlier literature implied [s3] and away from a direct causal pathway [s4].

Anyone told that treating their gums will reduce their cardiovascular risk is being offered a claim that the American Heart Association declined to endorse in 2012 [s1] and that subsequent evidence has not rescued. This article is informational and is not medical advice; decisions about periodontal treatment or cardiovascular risk belong with a dentist and a physician respectively.